According to a new market research
report published by Inkwood Research, the Global Pharmaceutical Continuous
Manufacturing Market is estimated to record a CAGR of 8.45% during the
forecasting years of 2020-2028.
“Browse 33 Market Data Tables and 40
Figures spread over 162 Pages, along with an in-depth TOC on the Global
Pharmaceutical Continuous Manufacturing Market Forecast 2020-2028.”
REQUEST FREE SAMPLE LINK- https://www.inkwoodresearch.com/reports/pharmaceutical-continuous-manufacturing-market/#request-free-sample
VIEW TABLE OF CONTENT LINK- https://www.inkwoodresearch.com/reports/pharmaceutical-continuous-manufacturing-market/#table-of-contents
Continuous
manufacturing is an advanced method, which is performed by applying constant
flow and combining all the manufacturing sub-processes into a whole with a
significant level of strategic control. The product is classified into
integrated continuous systems, semi-continuous systems, and control &
software. The advantages of continuous manufacturing systems such as lessened
fluctuation in production, enhanced yields, lower cost of operation, and equipment,
are promoting the market growth. In addition, FDA initiatives for encouraging
the use of pharmaceutical continuous manufacturing system and the benefit of CM
systems compared to batch manufacturing, are the significant factors augmenting
the market growth. Further, the CM process curbs processing time, helps to
enhance productivity, minimizes energy waste, and decreases energy needs. These
factors are creating lucrative opportunities for the market.
Growing Adoption of Pharmaceutical Continuous Manufacturing Systems Propels
Market Growth
The adoption
of continuous manufacturing systems is expanding since the last couple of years
as compared with the existing drug manufacturing process, owing to the
advantages offered by these systems. These systems are used to provide
pharmaceutical products with better quality, improved yield, and reduced cost,
within a short span of time. The adoption of CM systems over the existing drug
manufacturing process has grown in recent years, owing to technological
developments in CM system, rise in initiatives by the regulatory authorities
for adoption of CM, and increase in awareness about the benefits offered by CM
systems.
Integrated Continuous System Holds
the Largest Share in the End-User Segment
The integrated continuous manufacturing segment is dominating the
market and is expected to grow considerably during the forecast period. This is
on account of the fact that integrated continuous systems are used to produce
pharmaceutical products of excellent quality, enhance yield, and reduces cost
by curbing processing time. These systems are time-efficient, does not involve
any manual handling, increases occupational safety, and improves production
efficiency.
Asia Pacific Projected to Register
the Highest CAGR by 2028
The
pharmaceutical continuous manufacturing market of Asia Pacific is anticipated
to grow with the fastest CAGR during the forecast period. The presence of a
large population, increasing awareness about pharmaceutical continuous
manufacturing systems, a rise in demand for continuous manufacturing systems,
and the increasing number of pharmaceutical companies, are boosting the market
growth in the region.
Some of the
renowned companies operating in the market are GEA Group, Eli Lilly and
Company, KORSCH AG, Glatt GmbH, Pfizer Inc, etc. In the pharmaceutical continuous
manufacturing market, the growth of the industries is high, and product
differentiation is low. The companies are not willing to divert from their
businesses as there is a considerable amount of investments involved. Thus, the
intensity of the competition is moderate to high in the market.
About Inkwood Research
Inkwood
Research specializes in syndicated & customized research reports and
consulting services. Market intelligence studies with relevant fact-based
research are customized across industry verticals such as technology,
automotive, chemicals, materials, healthcare, and energy, with an objective
comprehension that acknowledges the business environments. Our geographical
analysis comprises of North & South America, CEE, CIS, Middle East, Europe,
Asia, and Africa.
Contact Us
+1 857-302-4704
Related Report:
No comments:
Post a Comment